COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC and research information from NIH.

U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:

Identification of p53 Activators in a Human Microarray Compendium, Tox21 Positive Results

Biomarkers predictive of molecular and toxicological effects are needed to interpret emerging high-throughput transcriptomic data streams. The TGx-DDI biomarker was compared to microarray data in a compendium derived from human cells using the Running Fisher test, a nonparametric correlation test. In addition, the Tox21 p53 assay examined p53 responses at multiple doses at 16 h and in parallel identified doses that were cytotoxic. This dataset contains 19 biosets that were positive in the Tox21 Assay.

Please download whole dataset from FTP

  • Primary Search Criteria
Bioset name Chemical Time (hr) Concentration (uM) Study Biosource TGx-DDI Biomarker (-log(p-value)) Possible Mechanism Comments Classification According to Table S3 in Li et al. A References (PubMed ID)

A Li, H.H., Hyduke, D.R., Chen, R., Heard, P., Yauk, C.L., Aubrecht, J. and Fornace, A.J. Jr. (2015). Development of a toxicogenomics signature for genotoxicity using a dose-optimization and informatics strategy in human cells. Environ Mol Mutagen. Jul;56(6):505-19, PMID: 25733355